Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,308
archived clinical trials in
Hepatitis

Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated:  2/26/2014
Henry Ford Hospital and Health System
mi
from
Detroit, MI
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated: 2/26/2014
Henry Ford Hospital and Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated:  2/26/2014
St.Louis University
mi
from
St. Louis, MO
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated: 2/26/2014
St.Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated:  2/26/2014
Medical Pro-care
mi
from
Flushing, NY
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated: 2/26/2014
Medical Pro-care
mi
from
Flushing, NY
Click here to add this to my saved trials
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated:  2/26/2014
North Shore-LIJ Health System
mi
from
Manhasset, NY
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated: 2/26/2014
North Shore-LIJ Health System
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated:  2/26/2014
Bon Secours St. Mary's Hospital of Richmond
mi
from
Newport News, VA
Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B
A Phase 2, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of GS-4774 for the Treatment of Virally-Suppressed Subjects With Chronic Hepatitis B
Status: Enrolling
Updated: 2/26/2014
Bon Secours St. Mary's Hospital of Richmond
mi
from
Newport News, VA
Click here to add this to my saved trials
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Status: Enrolling
Updated:  3/6/2014
OSF St. Francis Medical Center
mi
from
Peoria, IL
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome
Status: Enrolling
Updated: 3/6/2014
OSF St. Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Ultrasound Method to Measure Fibrosis of the Liver in Children
Sonoelastography: Ultrasound Method to Measure Fibrosis of the Liver in Children
Status: Enrolling
Updated:  3/11/2014
Massachusetts General Hospital
mi
from
Boston, MA
Ultrasound Method to Measure Fibrosis of the Liver in Children
Sonoelastography: Ultrasound Method to Measure Fibrosis of the Liver in Children
Status: Enrolling
Updated: 3/11/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Armodafinil for Patients Starting Hepatitis C Virus Treatment
Armodafinil for Patients Starting Hepatitis C Treatment
Status: Enrolling
Updated:  3/12/2014
Mount Sinai Medical Center
mi
from
New York City, NY
Armodafinil for Patients Starting Hepatitis C Virus Treatment
Armodafinil for Patients Starting Hepatitis C Treatment
Status: Enrolling
Updated: 3/12/2014
Mount Sinai Medical Center
mi
from
New York City, NY
Click here to add this to my saved trials
Armodafinil for Patients Starting Hepatitis C Virus Treatment
Armodafinil for Patients Starting Hepatitis C Treatment
Status: Enrolling
Updated:  3/12/2014
New York Presbyterian Weill Cornell Medical Center
mi
from
New York City, NY
Armodafinil for Patients Starting Hepatitis C Virus Treatment
Armodafinil for Patients Starting Hepatitis C Treatment
Status: Enrolling
Updated: 3/12/2014
New York Presbyterian Weill Cornell Medical Center
mi
from
New York City, NY
Click here to add this to my saved trials
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated:  3/19/2014
Massachusetts General Hospital
mi
from
Boston, MA
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated: 3/19/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated:  3/19/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated: 3/19/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated:  3/19/2014
Dana-Farber Cancer Institute
mi
from
Boston, MA
Sorafenib for Hepatocellular Cancer With Chronic Hepatitis C
A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Status: Enrolling
Updated: 3/19/2014
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated:  3/25/2014
Clinical Research Facility
mi
from
Miami, FL
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated: 3/25/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated:  3/25/2014
Clinical Research Facility
mi
from
Orlando, FL
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated: 3/25/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated:  3/25/2014
Clinical Research Facility
mi
from
St. Paul, MN
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated: 3/25/2014
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated:  3/25/2014
Clinical Research Facility
mi
from
San Antonio, TX
Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics of GS-5816 in Subjects With Normal Renal Function and Severe Renal Impairment
Status: Enrolling
Updated: 3/25/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)
A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  3/28/2014
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)
A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 3/28/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)
A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  3/28/2014
Clinical Research Facility
mi
from
Arlington, TX
A Study of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)
A Phase II Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen MK-5172 and MK-8742 ± Ribavirin (RBV) in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 3/28/2014
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Safety and Efficacy of MK-5172 + MK-8742 in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052/C-SURFER)
A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic Hepatitis C Virus Infection and Chronic Kidney Disease
Status: Enrolling
Updated:  4/4/2014
Clinical Research Facility
mi
from
Coronado, CA
Safety and Efficacy of MK-5172 + MK-8742 in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052/C-SURFER)
A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic Hepatitis C Virus Infection and Chronic Kidney Disease
Status: Enrolling
Updated: 4/4/2014
Clinical Research Facility
mi
from
Coronado, CA
Click here to add this to my saved trials
Safety and Efficacy of MK-5172 + MK-8742 in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052/C-SURFER)
A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic Hepatitis C Virus Infection and Chronic Kidney Disease
Status: Enrolling
Updated:  4/4/2014
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Efficacy of MK-5172 + MK-8742 in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052/C-SURFER)
A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects With Chronic Hepatitis C Virus Infection and Chronic Kidney Disease
Status: Enrolling
Updated: 4/4/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Boceprevir in End Stage Renal Disease (ESRD)
Prospective, Single-Center, Open Label, Pilot Study of Safety and Efficacy of Triple Anti-Viral Therapy With Pegylated Interferon, Ribavirin, and Boceprevir in Patients With Genotype 1 Chronic Hepatitis C (HCV) With End Stage Renal Disease (ESRD)
Status: Enrolling
Updated:  4/10/2014
Columbia University Medical Center - NYPH
mi
from
New York, NY
Boceprevir in End Stage Renal Disease (ESRD)
Prospective, Single-Center, Open Label, Pilot Study of Safety and Efficacy of Triple Anti-Viral Therapy With Pegylated Interferon, Ribavirin, and Boceprevir in Patients With Genotype 1 Chronic Hepatitis C (HCV) With End Stage Renal Disease (ESRD)
Status: Enrolling
Updated: 4/10/2014
Columbia University Medical Center - NYPH
mi
from
New York, NY
Click here to add this to my saved trials
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C
Status: Enrolling
Updated:  4/10/2014
Louis Stokes Cleveland VA Medical Center
mi
from
Cleveland, OH
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir and Re-assessment of Treatment Duration in Patients With Chronic Hepatitis C
Status: Enrolling
Updated: 4/10/2014
Louis Stokes Cleveland VA Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ultrasound Based Acoustic Radiation Force Impulse, Shear Wave Velocity Imaging in Pediatric Patients Undergoing Liver Biopsy
Status: Enrolling
Updated:  6/4/2014
University of Michigan Health System
mi
from
Ann Arbor, MI
Ultrasound Based Acoustic Radiation Force Impulse, Shear Wave Velocity Imaging in Pediatric Patients Undergoing Liver Biopsy
Status: Enrolling
Updated: 6/4/2014
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Status: Enrolling
Updated:  6/19/2014
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Status: Enrolling
Updated: 6/19/2014
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Status: Enrolling
Updated:  6/19/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Status: Enrolling
Updated: 6/19/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172 (MK-5172-013)
An Open-label, 3-Part, Multiple Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172
Status: Enrolling
Updated:  7/21/2014
Clinical Research Facility
mi
from
Orlando, FL
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172 (MK-5172-013)
An Open-label, 3-Part, Multiple Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172
Status: Enrolling
Updated: 7/21/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172 (MK-5172-013)
An Open-label, 3-Part, Multiple Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172
Status: Enrolling
Updated:  7/21/2014
Clinical Research Facility
mi
from
Knoxville, TN
Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172 (MK-5172-013)
An Open-label, 3-Part, Multiple Dose Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of MK-5172
Status: Enrolling
Updated: 7/21/2014
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
An Open Label, Pilot Study to Investigate the Safety and Efficacy of 12 Weeks of Simeprevir and Sofosbuvir, for HIV-infected, HCV Genotype 1 Patients With Advanced Fibrosis
Status: Enrolling
Updated:  7/30/2014
San Francisco General Hospital, University of California, San Francisco
mi
from
San Francisco, CA
A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C
An Open Label, Pilot Study to Investigate the Safety and Efficacy of 12 Weeks of Simeprevir and Sofosbuvir, for HIV-infected, HCV Genotype 1 Patients With Advanced Fibrosis
Status: Enrolling
Updated: 7/30/2014
San Francisco General Hospital, University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
TD-6450 SAD and MAD in Healthy Subjects
A Double-Blinded, Randomized, Placebo-Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of TD-6450, a NS5A Inhibitor, in Healthy Subjects
Status: Enrolling
Updated:  8/18/2014
ICON Development Solutions
mi
from
San Antonio, TX
TD-6450 SAD and MAD in Healthy Subjects
A Double-Blinded, Randomized, Placebo-Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of TD-6450, a NS5A Inhibitor, in Healthy Subjects
Status: Enrolling
Updated: 8/18/2014
ICON Development Solutions
mi
from
San Antonio, TX
Click here to add this to my saved trials
TD-6450 MAD Study in HCV Infected Subjects
A Double-Blinded, Randomized, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Antiviral Activity of TD-6450, a NS5A Inhibitor, in Treatment Naïve Subjects With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
Status: Enrolling
Updated:  8/18/2014
Texas Liver Institute
mi
from
San Antonio, TX
TD-6450 MAD Study in HCV Infected Subjects
A Double-Blinded, Randomized, Placebo-Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Antiviral Activity of TD-6450, a NS5A Inhibitor, in Treatment Naïve Subjects With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)
Status: Enrolling
Updated: 8/18/2014
Texas Liver Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
New Haven, CT
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Falls Church, VA
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Falls Church, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Detroit, MI
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Indianapolis, IN
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Dallas, TX
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Bronx, NY
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Hillsborough, NJ
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Hillsborough, NJ
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Philadelphia, PA
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Cincinnati, OH
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Newark, NJ
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Lutherville, MD
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Lutherville, MD
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Buffalo, NY
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Durham, NC
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
San Francisco, CA
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Allentown, PA
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
San Francisco, CA
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Neptune, NJ
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated:  11/5/2014
Clinical Research Facility
mi
from
Sacramento, CA
An Efficacy and Safety Study of MK-5172 + MK-8742 in the Treatment of Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naïve Subjects With Chronic HCV GT1, GT4, and GT6 Infection Who Are on Opiate Substitution Therapy
Status: Enrolling
Updated: 11/5/2014
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade.
Status: Enrolling
Updated:  11/16/2014
Massachusetts General Hospital
mi
from
Boston, MA
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
Evaluate the Utility of Shear Wave Sonoelastography as a Tool to Measure Liver Fibrosis Grade.
Status: Enrolling
Updated: 11/16/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Herpes Simplex Type 1 Suppression in Hepatitis C
HSV-1 Suppression in HCV Infected Veterans Who Are Seronegative for HSV-2
Status: Enrolling
Updated:  11/24/2014
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
mi
from
Jackson, MS
Herpes Simplex Type 1 Suppression in Hepatitis C
HSV-1 Suppression in HCV Infected Veterans Who Are Seronegative for HSV-2
Status: Enrolling
Updated: 11/24/2014
G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS
mi
from
Jackson, MS
Click here to add this to my saved trials